Clinical trial to research a novel biomarker of PSK responders in patients with colorectal cancer

ABSTRACT: Interventions: 1)Curative resection 2)UFT (Stage II) or UFT/LV (Stage III) combined with PSK for 1 year Primary outcome(s): 3 years disease free survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2625436 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR